Plus, news about Unicycive, Harbour BioMed, Omeros, Gilead, Repare Therapeutics, Vaccinex and Foresee Pharmaceuticals.
💼 InflaRx seeks to revive Gohibic in skin condition: After stopping a trial of the complement inhibitor in pyoderma gangrenosum ...
↧